Navigation Links
Halozyme Reports Second Quarter 2012 Financial Results
Date:8/6/2012

ctors, including unexpected expenditures, clinical trial results, delays in development and regulatory review, regulatory approval requirements and competitive conditions. These and other factors that may result in differences are discussed in greater detail in the Company's reports on Forms 10-K, 10-Q, and other filings with the Securities and Exchange Commission.

Media/Investor Contact:
Anne Erickson
Executive Director
Halozyme Therapeutics
858-704-8264
aerickson@halozyme.com

 Halozyme Therapeutics, IncUnaudited Condensed Consolidated Statements of Comprehensive Income (Loss)Three Months EndedSix Months EndedJune 30, June 30, 2012201120122011REVENUES:Product sales, net

$
524,942$
5,470$
712,353$
330,919Revenues under collaborative agreements

7,232,23323,023,47814,485,00130,401,922Total revenues

7,757,17523,188,94815,197,35430,732,841OPERATING EXPENSES:Cost of product sales

143,120178,235213,881189,952Research and development

16,081,72915,347,11631,972,83829,132,913Selling, general and administrative

5,580,4244,567,66612,199,1317,973,632Total operating expenses

21,805,27320,093,01744,385,85037,296,497OPERATING INCOME (LOSS)

(14,048,098)3,095,931(29,188,496)(6,563,656)Interest and other income, net

26,97920,35748,19644,226NET INCOME (LOSS)

$ (14,021,119)$  3,116,288$ (29,140,300)$ (6,519,430)Basic and diluted net income (loss) loss per share

$
(0.13)$
.03$
(0.27)$
(0.06)Shares used in computing net income (loss)  per share:Basic

112,063,665102,671,410109,826,589101,804,887Diluted

112,063,665104,393,835109,826,589101,804,887COMPREHENSIVE INCOME (LOSS)

$ (14,021,119)$  3,116,288$ (29,140,300)$ (6,519,430) Halozyme Therapeutics, IncUnaudited Condensed Consolidated Balance SheetsJune 30, December 31,20122011ASSE
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
2. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
3. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
4. Halozyme Reports First Quarter 2012 Financial Results
5. Halozyme to Host First Quarter 2012 Financial Results Conference Call
6. Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2012
7. Press Ganey Releases Enhanced Improvement Portal with Customized Performance Reports
8. Isis Reports Financial Results And Highlights For Second Quarter 2012
9. Champions Oncology Reports Resignation Of Director
10. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
11. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... CHENGDU, China , Jan. 23, 2015 Tianyin ... pharmaceutical company that specializes in the development and sale ... branded generics and active pharmaceutical ingredients (API) today announced ... Facility (JCM) API operation. 1. Following the ...
(Date:1/22/2015)... /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), ... for cardiovascular disease and overall health is pleased to provide ... and its outlook for 2015 from the CEO, Mr. ... We would like to take this opportunity to share with ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Infectious Disease Diagnostics Market by Product, Application, Technology, ... to their offering. , The infectious disease ... 7.9% to reach $18,156.2 million by 2019 from $12,422.8 ...
Breaking Medicine Technology:TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3
... Calif., Aug. 20 Jazz Pharmaceuticals, Inc. (Nasdaq: ... Committee of the U.S. Food and Drug Administration (FDA), ... and Risk Management Advisory Committee, voted 20-2 that the ... for the treatment of fibromyalgia with the currently proposed ...
... Cumberland Pharmaceuticals Inc.(Nasdaq: CPIX ) today ... its review of the supplemental new drug application (sNDA) for ... with non-acetaminophen acute liver failure. The review has been extended ... Fee Act (PDUFA) goal date in December 2010. ...
Cached Medicine Technology:Jazz Pharmaceuticals Provides Update on FDA Advisory Committee Meeting For JZP-6 (Sodium Oxybate) in Fibromyalgia 2Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application 2Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application 3
(Date:1/22/2015)... The City of West Hollywood hosted a news conference on ... anniversary of the Supreme Court decision Roe v. Wade, which legalized ... the Roe vs. Wade decision and the fight to protect a ... City of West Hollywood Councilmember Abbe Land. “We need to continue ...
(Date:1/22/2015)... 2015 Gabe’s Chemo Duck Program is pleased to ... app ever created for kids with cancer. The Chemo Duck App, ... is filled with enjoyable games to help children of all ages ... app helps to keep kids entertained, educated and at ease while ...
(Date:1/22/2015)... 23, 2015 VogueQueen is a seasoned and ... and many designers are thrilled to have it lead the ... its new collection of prom dresses for the global market. ... the strategic vision and he focuses on continuing the goal ...
(Date:1/22/2015)... 2015 Angelweddingdress is a famous wedding dress ... customers to follow it on Facebook, Twitter, and Pinterest. The ... gift. Angelweddingdress draws a lottery every week. , Moreover, the ... 28, 2015. Click Angelweddingdress homepage for more information. ...
(Date:1/22/2015)... 23, 2015 AngelWeddingDress, the premier women’s ... maternity wedding dresses. View website of AngelWeddingDress.com ... for maternity wedding dresses online for a bridal party. ... high quality for them. Its maternity wedding dresses are ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2
... so will potential risks, researcher warns , FRIDAY, May ... defibrillators and cochlear implants, are becoming vulnerable to "infection" ... To prove his point, Mark Gasson, a scientist at ... himself to become "Exhibit A." , Gasson said he ...
... (May 28, 2010)Cancer of the pancreasa glandular organ ... and hormonesseldom is detected in early stages, making treatment ... research from Fox Chase Cancer Center finds that patients ... chemotherapy and radiation survive four times as long, on ...
... ... ... Clubs International Foundation (LCIF), will appear in Monday’s National Memorial Day Parade along ... who are Lions Clubs members. , , ,One of the WWII veterans on the float will ...
... ... solutions arena with the addition of two respected Atlanta-area surgical assistant practices: Omni Surgical ... ... (JSA) has expanded its national presence in the practice management solutions arena with the ...
... Khanna ... ... have had a symbiotic relationship to advance vision in people suffering from presbyopia or cataracts. ... RK or macular degeneration. The Crystalens is the only FDA approved accommodating intraocular lens ...
... are studying the role that statins lifesavers for tens ... play in causing disabling tendon ruptures. Francesca Dwamena, ... of Medicine, is leading the study, which will analyze more ... by a grant from the Blue Cross Blue Shield of ...
Cached Medicine News:Health News: Scientist Becomes First Human 'Infected' With Computer Virus 2Health News:Response to preoperative therapy may predict survival in pancreatic cancer patients 2Health News:Chairman Al Brandel of Lions Clubs International Foundation to Appear in Washington DC's National Memorial Day Parade 2Health News:Jackson Surgical Assistants Expands Its National Presence by Merging with Two Atlanta Area Practices 2Health News:Jackson Surgical Assistants Expands Its National Presence by Merging with Two Atlanta Area Practices 3Health News:Khannna Institute to offer Crystalens in Quarter Diopter Steps 2Health News:MSU team studies connection between statins, tendon ruptures 2
... enables hospitals to standardize ... to a single temperature ... monitoring disposale probes and ... in their manufacture and ...
... The pause of a heartbeat. The ... of rhythmic breathing. These vital signs are ... check. DeRoyals line of Temperature Monitoring products ... the information needed to provide the most ...
... The pause of a heartbeat. The ... of rhythmic breathing. These vital signs are ... check. DeRoyals line of Temperature Monitoring products ... the information needed to provide the most ...
... stabilization of the capsular bag in complicated ... Tension Ring has application in several different ... available for patients with pseudoexfoliation syndrome. Many ... tension ring, especially those in whom you ...
Medicine Products: